Epsom, UK, 9th February 2017 / Sciad Newswire / Now is the time for the consumer electronics industry to adopt plastic electronics as new devices are set to revol

Medherant Ltd., a University of Warwick spin-out developing a novel transdermal drug delivery patch technology, is pleased to announce the appointment of Dr Ken Cunningham as Chair. Dr Cunningham joins Medherant as the company prepares to move into clinical studies with its leading TEPI Patch® technology.

Prokarium and Probiomed today announced the start of their collaboration to scale-up the manufacture of orally administered vaccines in a formulation that would enable stability at 40°C for several weeks. The first vaccine to be manufactured will be developed to prevent so-called ‘Montezuma’s revenge’ or diarrhoea, which affects the local population as well travellers in Mexico and many countries.

NALIA Systems, a developer of novel multiplex immunodiagnostic systems for clinical and research applications, announces the expansion of its board following the recent successful £500,000 fund raising.